HARCP

HEROIN ADDICTION AND
RELATED CLINICAL PROBLEMS

The official journal of
EUROPAD - European Opiate Addiction Treatment Association
WFTOD - World Federation for the Treatment of Opioid Dependence
Editor: Icro Maremmani, MD - Pisa, Italy, EU
Associate Editors:
Thomas Clausen, MD - Oslo, Norway
Pier Paolo Pani, MD - Cagliari, Italy, EU
Marta Torrens, MD - Barcelona, Spain, EU
Statistical Editor:
Mario Miccoli, PhD - Pisa, Italy, EU

HARCP Archives

Browse by article Browse by volume    

Heroin Addiction and Related Clinical Problems: 2001, 03, 2 (pages: 21 - 28)

Evaluation survey of a Methadone Treatment share care programme between a specialized clinic and a network of GPs

Coppel A., Bloch-Laine J. F., Charpak Y., Spira R.

Summary: Emergence Espace-Tolbiac is a methadone treatment clinic. Over the last 5 years, EET has initiated methadone treatment with 738 patients, including 548 who have been referred to a network of 220 GPs The way of service functions is defined by the French regulations for methadone treatment. Such treatment must be initiated by specialized clinics, but once patients have stabilized, can be referred to GPs. Our service initiates the treatment, and patients stay at the clinic, where methadone is administered every day by a specialized team. During the first few weeks, the patient's needs are evaluated and he or she is referred to various professionals, such as social workers, doctors and psychiatrists, according to whatever is appropriate in each case. Patients are referred to GPs when the evaluation is made that they no longer abuse drugs such as heroin or cocaine, or other substances such as alcohol or benzodiazepine. They must have social resources and available accommodation. Patients suffering from a psychiatric disorder do not receive referrals until their condition has been stabilized by any kind of treatment. So far 40% of our patients have received a referral after an average of 2 months at the clinic, and 30% after an average of 9 months, while 18% have stayed at the clinic for over 2 years. A follow-up has been conducted on 296 patients referred to GPs (32 GPs failed to answer) After an average of a year and a half on treatment, 5% were no longer available for follow-up, and 85% are still being advised by their GP. Of these, 95% are still being treated with methadone. Most of the others (9/13), are being treated with high-dosage buprenorphine (Subutex). The mean dosage is 60mg/day, 15 mg less than at the end of the stay at the centre. Relationships with other professionals are frequent (67% of patients). 20% are still in contact with the centre

 

AU-CNS Associazione per lā€™Utilizzo delle Conoscenze Neuroscientifiche a fini Sociali
Association for the Application of Neuroscientific Knowledge to Social Aims
Via XX Settembre, 83 ā€“ 55045 PIETRASANTA (Lucca) - Italy
P. IVA 01681650469 ā€“ Codice Fiscale 94002580465 Reserved Area
Tel/Phone: 0584 - 790073 - Email: info@heroinaddictionrelatedclinicalproblems.org
Start of page